Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Inflamm Bowel Dis. 2013 Mar-Apr;19(4):779–784. doi: 10.1097/MIB.0b013e3182802b0e

Table 2.

Comparative characteristics of patients with evidence of any endoscopic inflammation (Mayo sub-score > 0, n=67), and those with no endoscopic inflammation (n=82)

Variable Endo. Active Endo. Normal
Mean Age in yrs (SEM) 48 (2) 54 (2)
Male (%) 49 50
Mean Disease Duration in yrs (SEM) 20 (3) 22 (3)
Clinical Remission > 6 months (%) 69 90
Steroid use in last 12 months (%) 21 6
Disease geography
 Left-sided colitis (%) 51 54
 Extensive colitis (%) 49 40
Current medications
 Mesalamine (%) 82 72
 Azathioprine / mercaptopurine (%) 21 16
 Infliximab (%) 9 4
Laboratory Markers (SEM)
 WCC (K/uL) 6.8 (0.2) 5.9 (0.2)
 Hematocrit (%) 41 (0.4) 41 (0.4)
 ESR (mm/hr) 11 (1) 11 (1)
 CRP (mg/L) 4.8 (0.4) 2.4 (0.4)
Mean Histological score 1.7 (0.2) 1.6 (0.2)